< a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=_O1F1mK6Taw:BUHqFXVWbJA:yIl2AUoC8zA" > < img..."> < a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=_O1F1mK6Taw:BUHqFXVWbJA:yIl2AUoC8zA" > < img..." /> < a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=_O1F1mK6Taw:BUHqFXVWbJA:yIl2AUoC8zA" > < img..." />

Sales of flagship drug Revlimid drive Celgene profit; forecast raised

NEW YORK (Reuters) - Celgene Corp raised its 2016 profit forecast and exceeded expectations for second-quarter earnings on Thursday on the strength of its flagship multiple myeloma drug Revlimid and growth in newer medicines, sparking a 2 percent jump in its shares. < div class="feedflare" > < a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=_O1F1mK6Taw:BUHqFXVWbJA:yIl2AUoC8zA" > < img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0" > < /img > < /a > < a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=_O1F1mK6Taw:BUHqFXVWbJA:F7zBnMyn0Lo" > < img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=_O1F1mK6Taw:BUHqFXVWbJA:F7zBnMyn0Lo" border="0" > < /img > < /a > < a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=_O1F1mK6Taw:BUHqFXVWbJA:V_sGLiPBpWU" > < img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=_O1F1mK6Taw:BUHqFXVWbJA:V_sGLiPBpWU" border="0" > < /img > < /a > < /div > < img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/_O1F1mK6Taw" height="1" width="1" alt=""/ >
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news